The b 2 -adrenoceptor (b2AR) signal transduction system plays an essential role in cardiovascular regulation. Therefore variation in the b2AR gene (ADRB2) could have major clinical implications. The most common single-nucleotide polymorphisms (SNPs) in ADRB2 occur at nucleotide position 46, which carries either adenine or guanine and results in an amino acid change at position 16 (Arg16Gly) and at nucleotide position 79, which carries either cytosine or guanine and results in an amino acid change at position 27 (Gln27Glu). These SNPs are in linkage disequilibrium, with Glu27 homozygotes nearly always homozygous for Gly16 and Arg16 homozygotes almost always homozygous for Gln27. 1 2 The impact of these SNPs on in vitro responses has been extensively reviewed. 3 For example, Gly16 was shown to result in increased agonist-induced desensitization compared with Arg16. 4 However, while the b2AR is responsible for vasodilation via the cAMP pathway in smooth muscle cells, clinical studies have demonstrated conflicting results. Infusion of b2AR agonists into the brachial artery evoked greater vasodilation in Gly16 than in Arg16 homozygotes. 5 6 Moreover, perfusion of hand veins with isoproterenol resulted in greater maximum venodilation in Gly16+Glu27 homozygotes compared with Gly16+Gln27 and Arg16+Gln27 homozygotes, respectively. 7 In contrast, systemic infusion studies revealed either greater systemic vasodilatation in Arg16 homozygotes compared with Gly16 homozygotes 8 -10 or no difference between genotypes. 11 12 in the ADRB2 might be revealed and contribute to an understanding of the significance of genetic variations for cardiovascular regulation under anaesthesia. Accordingly, we tested the hypothesis that during sympathetic neural block by thoracic epidural anaesthesia (TEA), greater b2AR signalling in Gly16 and Glu27 allele carriers results in greater hypotension and increased vasopressor requirements.
Methods

Study cohort
After approval from the University Hospital Essen Institutional Review Board and informed written consent from each patient, this prospective, double-blind study was performed in adult patients of Caucasian ethnicity undergoing major abdominal surgery (hepatectomy, liver resection, gastrectomy, and Whipple operation) during combined general anaesthesia and TEA at the University Hospital Essen, Germany. Exclusion criteria included ASA physical status IV, severe coronary heart disease, high-grade valvular stenosis or insufficiency, cardiac failure, pulmonary hypertension, right ventricular failure, chronic respiratory insufficiency, coagulopathy, anticoagulant medication, or refusal of epidural anaesthesia. Of 258 patients initially screened for eligibility to participate between April 2, 2009, and August 23, 2011, 108 were ineligible due to exclusion criteria and 35 patients refused to participate. Of 115 subjects enrolled, 22 could not be assessed due to their poor compliance and understanding (warm/cold discrimination), therapyresistant hypertension, and/or failed DNA analysis. Eventually, 93 subjects were analysed. The study outline is depicted in Figure 1 .
Study protocol
On the morning of surgery, all subjects received 0.1 mg kg 21 midazolam 30 min before transfer into the operating theatre. After connecting standard cardiorespiratory monitoring according to departmental guidelines, an i.v. crystalloid infusion was started via a peripheral vein. Non-invasive arterial pressure, respiratory rate, electrocardiogram, and pulse oximetry were continuously recorded. Consecutively, a radial artery line was placed with the patient in the supine position followed by recording of baseline mean arterial pressure (MAP) and heart rate (HR) after a 5 min rest. A thoracic epidural catheter (TEA, Th6/7 -Th9/10) was placed using a median approach and the loss-of-resistance technique in a seated position, and a test dose of 3 ml isobaric bupivacaine 0.5% was applied. After 5 min in the supine position, 10 ml isobaric bupivacaine 0.5% was applied via epidural catheter and MAP and the extent of sensory block (warm/cold discrimination) was recorded continuously for 20 min in the supine position while awake. After a standardized anaesthetic induction using thiopental 5 mg kg 21 
Genotyping
Arterial blood samples (10 ml, EDTA tubes) were obtained from all subjects in the operating theatre before induction of epidural anaesthesia. DNA was extracted from leucocytes using standard techniques (QIAgen, Hilden, Germany). The following ADRB2 SNPs were genotyped: Arg16Gly (nucleotide 46 A/G, rs1042713) and Gln27Glu (nucleotide 79 C/G, rs1042714).
Genotyping was performed as previously described 13 using the slowdown PCR method. 14 Haplotypes were inferred using the expectation maximization (EM) algorithm. Three common haplotypes were inferred in the population: Arg16Gln27, Gly16Glu27, and Gly16Gln27.
Statistical considerations
Sample size calculation
The study was powered to detect a difference induced by a genetic covariate of 300 mg phenylephrine with a variance of 400 mg, similar to the magnitude of the effect in a previous study in pregnant patients undergoing Caesarean section under spinal anaesthesia. 15 Minor allele frequency (MAF) structure analysis in Caucasians revealed MAF Arg16Gly and Gln27Glu of at least 25% (Table 1) . 16 Given an a-error of 0.05, a power of 80%, and an MAF of 25%, we calculated a total sample size of 92.
Statistical analysis
Data are presented as mean (SD) unless otherwise indicated. All polymorphisms were tested for conformation with the HardyWeinberg equilibrium using the goodness-of-fit (14) 10 (26) 13 (27) 7 (30) 13 (30) 4 (15) with cumulative phenylephrine dose as the dependent variable without adjustment for covariates to test each variable's ability to predict phenylephrine requirements. Genotypes were dummy coded for the regression. All variables that were significant at a level ,0.1 were then included in a multiple linear regression analysis in a stepwise fashion to determine the incremental improvement in model fit and explained variance as measured by r
2
. The final regression model underwent several tests to rule out violations of the linear regression model assumptions test for collinearity and variation inflation factor. Variation inflation factors ranged from 1.1 to 1.4. Tolerance values ranged between 0.71 and 0.96, arguing that collinearity was not a problem for multiple regression analysis. 17 An a priori a-error P,0.05 was considered statistically significant.
Results
For the 93 subjects analysed, comparison to Utah residents with ancestry from northern and western Europe from the Centre d ′ Étude du Polymorphisme Humain collection frequencies (HapMap-CEU) showed consistent ADRB2 MAF across both populations (Supplementary Table S1 ). Three haplotypes could be correctly inferred in our population with the following frequencies: Arg16Gln27, 0.29; Gly16Gln27, 0.19; Gly16Glu27, 0.52. This allowed us to infer all individual haplotype pairs with an accuracy of 1.0.
We detected no significant associations of the ADRB2 genotype and preoperative characteristics (Table 1) . Moreover, there was no association of the ADRB2 genotype with the type of operation (data not shown).
During the period of data acquisition, 86 (92%) subjects experienced a decrease in MAP ,70 mm Hg and hence required phenylephrine. The mean cumulative dose per subject, including doses administered before and after induction of general anaesthesia, averaged 654 mg (450). The ADRB2 Arg16Gly and Gln27Glu polymorphisms were significantly associated with vasopressor requirements (Table 2) . Moreover, analysis of haplotype pairs showed significant differences in phenylephrine dosage (Table 2) .
We then analysed separately the two time periods after initiation of TEA, before and after induction of general anaesthesia, for the respective vasopressor requirements. Within 20 min after epidural injection of 50 mg of bupivacaine in addition to the test dose, 36 subjects (39%) experienced arterial hypotension with MAP ,70 mm Hg and required phenylephrine. Glu27 allele carriers needed more phenylephrine compared with homozygous Gln27 subjects, while the Arg16Gly polymorphism was not associated with phenylephrine requirements (Table 2) . Furthermore, the time to critical hypotension was significantly shorter in Glu27 allele carriers compared with Gln27Gln carriers ( Fig. 2A; P¼0.034) . At 20 min after TEA, 78% of Gln27Gln subjects still had MAP .70 mm Hg compared with only 56% of Glu27 allele carriers [RR 2.9; 95% confidence interval (CI): 1.0-8.6; P¼0.05].
After induction of general anaesthesia, 85 subjects (91%) had hypotension and thus required phenylephrine. The Arg16Gly, Gln27Glu, and corresponding haplotype pairs were significantly associated with vasopressor requirements (Table 2 ). Gly16 allele and Glu27 allele carriers required almost twice as much phenylephrine after induction of general anaesthesia to maintain normotension compared with homozygous Arg16 and Gln27 subjects ( Table 2 ). Time to critical hypotension was significantly shorter in Glu27 allele carriers (time until 50% of subjects had MAP ,70 mm Hg averaged 4 min vs 9; P¼0.02) with a hazard ratio of 1.8 (95% CI: 1.1-2.9; Fig. 2B ).
Finally, we analysed whether subject and genetic factors were individually able to predict cumulative vasopressor requirements. Bivariate analyses with simple linear regression showed that gender, extent of rostral sensory block, baseline MAP, and the Glu27 allele were significantly associated with cumulative phenylephrine dose (Table 3) . Baseline MAP showed the largest contribution to phenylephrine dose (r 2 ¼0.21) followed by the Glu27 allele (r 2 ¼0.12).
In a multiple linear regression analysis, we analysed which model best predicted vasopressor requirements (Table 4) . While baseline MAP alone contributed to 20% of the variation in vasopressor requirements, the Glu27 allele explained an additional 10% of variance (Table 4 ). In total, ADRB2 Glu27, extent of rostral block, baseline MAP, and gender were able to explain 37% of the variation of phenylephrine requirements.
Discussion
To our knowledge, this is the first clinical study to evaluate the effect of various ADRB2 alleles on vascular responsiveness in patients with thoracic epidural combined with general anaesthesia. After sympathetic block by TEA, Gly16 and Glu27 allele carriers in the ADRB2 gene had greater vasopressor requirements to sustain arterial normotension compared with homozygous Arg16 and Gln27 carriers. More than 10% of the arterial pressure variance was explained by genetic variation, making ADRB2 variation the second most important and independent predictor of hypotension during epidural anaesthesia besides baseline arterial pressure. In a more general sense, our study also reveals that sympathetic block by TEA, with and without an additional challenge superimposed by general anaesthesia/mechanical ventilation, can unmask the influence of genetic variations on arterial pressure.
Several in vivo studies regionally administering b 2 -agonists reported greater vasodilation in Gly16, Glu27, or both allele carriers. 5 -7 Moreover, bronchodilation to inhaled albuterol in patients with asthma was greater in Gly16Glu27 haplotype carriers. 1 Greater b2AR receptor density in Gly16 vs Arg16 carriers may explain these results. 1 18 Finally, the Gly16 allele exhibits a higher functional responsiveness and diminished down-regulation upon isoproterenol stimulation. 19 However, ADRB2 variants and hypotension after TEA BJA studies using systemic b 2 -agonist administration with interference from baroreflexes showed no effect on systemic vascular reactivity 11 12 or greater systemic vasodilation in Arg16/Gln27 allele carriers. 8 -10 We speculated that apparent discrepancies in responses to b 2 -agonist administration might be explained by compensatory autonomic mechanisms. After autonomic ganglionic (sympathetic and parasympathetic) block by trimethaphan and subsequent terbutaline administration, Hesse and colleagues 18 found a greater decrease in systemic vascular resistance in Gly16 allele carriers compared with Arg16 allele carriers. Under these conditions, the Gly16Glu27 haplotype demonstrated augmented b2AR-mediated function. 18 Moreover, in the Swiss Beta Blocker in Spinal Anaesthesia study, Gly16 allele patients had more hypotensive episodes after spinal anaesthesia compared with Arg16 allele carriers. 20 These results indicate that genetic variants can reveal their influence only under haemodynamic challenges and sympathetic block.
To investigate the effects of ADRB2 polymorphisms, we focused on arterial pressure and vasopressor requirements under sympathetic block by widespread TEA. We measured sensory block by warm/cold discrimination, which showed that the majority of subjects had rostral block of Th2. While sympathetic block usually extends at least two or three dermatomes higher 21 and the most rostral thoracic sympathetic efferents leave the spinal cord not higher than T1, sympathetic block in our study should have extended to T1 in the majority of subjects. However, about 30% of subjects had a rostral extent of T3 and lower, resulting in the rostral extent of sensory block being a minor predictor of vasopressor requirements after TEA. The caudal spread of sensory block averaged L2/3, supporting a caudally unrestricted sympathetic block. 21 22 This is in line with our observation that the incidence of hypotension was unrelated to the extent of caudal block. Abolition of sympathetic outflow by TEA 23 decreases post-synaptic norepinephrine concentration, attenuates evoked vasoconstriction, and diminishes baroreflex-evoked renin release. 24 25 Accordingly, the relevance of the remaining b2AR system should be enhanced under such conditions. Our working hypothesis is that during sympathetic neural block, the greater b2AR signalling in Gly16 and Glu27 allele carriers (demonstrated in vitro) results in increased vasodilation and thus greater hypotension and increased vasopressor requirements. Our data are entirely consistent with this hypothesis by showing that Gly16, Glu27, and haplotype pairs harbouring the Gly16Glu27 haplotype are independent predictors of hypotension and vasopressor requirements. Interestingly, the greatest effect on vasopressor requirements was associated with the Gln27Glu polymorphism. While the Glu27 allele was always inherited with the Gly16 allele resulting in the Gly16Glu27 haplotype, analysis of the Gln27Glu polymorphism alone is sufficient to identify the Gly16Glu27 haplotype. Moreover, this suggests that the Gln27Glu variant is causative and that findings of an association with the Arg16Gly polymorphism might reflect the high linkage disequilibrium with Gln27Glu. This hypothesis is also in line with data showing the dominant effects of the Gln27Glu polymorphism. 26 Twenty-four subjects (26%) in our study group received b-blocker therapy. While an interaction of b-blocker therapy with neuraxial block is discussed, 20 we did not observe a significant effect of b-blocker therapy on phenylephrine requirement. This is in line with a study by Zaugg and colleagues 20 investigating the effect of b-blockade after spinal block, where the number of hypotensive episodes were not significantly different between patients with or without b-blocker therapy. 20 Our findings contrast with a publication investigating ADRB2 genotypes and vasopressor requirements after spinal anaesthesia in women undergoing elective Caesarean delivery, where homozygous Gly16Gly and Glu27Glu patients showed a lower requirement for vasopressor treatment of hypotension. 15 Moreover, another study in Chinese women undergoing China. Therefore, some of these discrepancies might be due to ADRB2 genotype differences among ethnic groups, resulting in different haplotype patterns. 16 For example, in the Chinese population, only 7% of patients were heterozygous for the Glu27 allele, which showed the strongest effect on vasopressor requirement in this study, with no patient being homozygous. 27 These data, therefore, confirm that data derived from genetic studies must always be considered with respect to ethnic background. Our results could be regarded as revealing a so-called 'intermediate phenotype', that is, a genotype influencing functional physiological characteristics without evoking pathological abnormalities. 28 However, the clinical implication of this investigation might be extended to population-based studies that suggest the Gly16, Glu27, or both alleles is favourable for cardiovascular health (reviewed in Nagele and Liggett). 29 For example, a prospective cohort study in patients with acute coronary syndrome showed that among patients treated with b-blockers, Arg16+Gln27 patients had the poorest survival, while patients homozygous for Gly16+Glu27 had favourable survival. 30 However, extension of the study and ethnicityspecific analysis suggested that the association was specific for African Americans. 31 Moreover, homozygosity for the Gln27 allele was reported to negatively affect outcome in heart failure. 32 33 Thus the augmented b2AR function in Gly16Glu27 haplotypes, which results in a greater vasodilatatory response, might be protective in hypertension or heart disease.
Limitations
We did not measure systemic vascular resistance since insertion of pulmonary artery catheters was not considered appropriate in our subjects. Accordingly, we do not know to what extent the genotype-related decrease in arterial pressure was due to a decrease in cardiac output, vascular resistance, or both. Furthermore, we did not measure catecholamine plasma concentrations or the concentrations of hormones such as vasopressin, renin, angiotensin, endothelin, or cGMP known to be altered by hypotension, epidural anaesthesia, or both. 34 35 Accordingly, we cannot pinpoint mechanisms by which the genetic variants evoked their effect on arterial pressure. Moreover, although the Arg16Gly and Gln27Glu SNPs have gained the majority of attention in clinical and molecular studies, we cannot rule out that other SNPs within the ADRB2 gene or in other genes such as ADRB1 have an impact on vascular reactivity, as relevant during epidural anaesthesia. Finally, although we found significant genotype-specific differences in vasopressor requirements, the study sample size is limited.
In conclusion, the ADRB2 Glu27 allele is a relevant and independent predictor of arterial hypotension and vasopressor requirements during sympathetic block by TEA. This work also illustrates the potential of using TEA as an investigational tool to unmask genetic causes for variations in the phenotype 'cardiovascular response to anaesthesia'. Anaesthesia and sympathetic block in general might serve as a suitable challenge to unmask genetic influences on human neurohumoral regulation.
